Andy Moye, PhD, is currently the Senior Vice President and General Manager of Data at Tempus, where they focus on enhancing patient outcomes in collaboration with pharmaceutical and life science partners. Previously, they served as CEO and Board Member of Paige, an AI cancer diagnostics firm that achieved the first FDA approval for AI in pathology. With over two decades of experience across biotechnology, life sciences, and molecular diagnostics, Andy has demonstrated expertise in leading organizations, driving innovation, and executing successful business strategies. They hold a PhD in Health Economics and an MBA, and are recognized for their contributions to precision medicine and cancer diagnostics. Andy's career is underscored by a commitment to improving patient care through advanced technologies and solutions.
This person is not in the org chart
This person is not in any teams
This person is not in any offices